- In
clinical trials,
reactogenicity is the
capacity of a
vaccine to
produce common, "expected"
adverse reactions,
especially excessive immunological responses...
- that
protect the RNA
strands and help
their absorption into the cells.
Reactogenicity, the
tendency of a
vaccine to
produce adverse reactions, is similar...
-
Clinical trial number NCT01160172 for "A
Study to
Evaluate the Safety,
Reactogenicity and
Immunogenicity of GSK Biologicals'
Staphylococcal Investigational...
-
which owns the
Brazilian substrain M.
bovis BCG
Moreau which is less
reactogenic than
vaccines including other BCG strains.
Pacis BCG, made from the Montréal...
-
currently used
anthrax vaccines show
considerable local and
general reactogenicity (erythema, induration, soreness, fever) and
serious adverse reactions...
-
Diseases (NIAID) (1 June 2018), A
Phase I
Trial to
Evaluate the Safety,
Reactogenicity, and
Immunogenicity of MVA-BN
Yellow Fever Vaccine With and Without...
- PMID 17458775. S2CID 21308968.
Clinical trial number NCT03392389 for "Safety,
Reactogenicity, and
Immunogenicity of mRNA-1653 in
Healthy Adults" at ClinicalTrials...
- on 8
August 2021.
Retrieved 17
January 2021. "Study of the Safety,
Reactogenicity and
Immunogenicity of "EpiVacCorona"
Vaccine for the
Prevention of COVID-19...
- but were
largely abandoned in the 1970s due to
their then-do****ented
reactogenicity and poor efficacy. Oral
cholera vaccines were
first introduced in the...
-
currently used
anthrax vaccines show
considerable local and
general reactogenicity (erythema, induration, soreness, fever) and
serious adverse reactions...
